Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Kreisler

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Parkinson'S Disease|January 8, 2024
The Use of Image Guided Programming to Improve Deep Brain Stimulation Workflows with Directional Leads in Parkinson's DiseaseAnne-Sophie Rolland, Gustavo Touzet, Nicolas Carriere, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 13, 2013
Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trialDavid Devos, Caroline Moreau, David Maltête, et al.
Clinical Neurology and Neurosurgery|May 3, 2016
Randomized placebo-controlled trial of sodium valproate in progressive supranuclear palsyLaurène Leclair-Visonneau, Tiphaine Rouaud, Bérangère Debilly, et al.
The Biochemical Journal|September 19, 2019
Centrosomal cohesion deficits as cellular biomarker in lymphoblastoid cell lines from LRRK2 Parkinson's disease patientsBelén Fernández, Antonio Jesús Lara Ordóñez, Elena Fdez, et al.
Neurobiology of Aging|January 26, 2010
Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutationEugénie Mutez, Lydie Larvor, Frédéric Leprêtre, et al.
NPJ Parkinson'S Disease|February 7, 2023
Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson's disease and pharmacodynamic biomarkersJean-Marc Taymans, Eugénie Mutez, William Sibran, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 10, 2016
Novel heterozygous mutation in ANO3 responsible for craniocervical dystoniaMorgane Miltgen, Arnaud Blanchard, Hélène Mathieu, et al.
Sensors (Basel, Switzerland)|March 26, 2022
Quantification of Head Tremors in Medical Conditions: A Comparison of Analyses Using a 2D Video Camera and a 3D Wireless Inertial Motion UnitDavid Amarantini, Isabelle Rieu, Giovanni Castelnovo, et al.
The New England Journal of Medicine|November 8, 2023
Trial of Botulinum Toxin for Isolated or Essential Head TremorAna Marques, Bruno Pereira, Marion Simonetta-Moreau, et al.
Journal of Neurology|January 12, 2024
Prognosis of impulse control disorders in Parkinson's disease: a prospective controlled studyThomas Wirth, Thibaut Goetsch, Jean-Christophe Corvol, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Parkinson'S Disease|January 8, 2024
The Use of Image Guided Programming to Improve Deep Brain Stimulation Workflows with Directional Leads in Parkinson's DiseaseAnne-Sophie Rolland, Gustavo Touzet, Nicolas Carriere, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 13, 2013
Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trialDavid Devos, Caroline Moreau, David Maltête, et al.
Clinical Neurology and Neurosurgery|May 3, 2016
Randomized placebo-controlled trial of sodium valproate in progressive supranuclear palsyLaurène Leclair-Visonneau, Tiphaine Rouaud, Bérangère Debilly, et al.
The Biochemical Journal|September 19, 2019
Centrosomal cohesion deficits as cellular biomarker in lymphoblastoid cell lines from LRRK2 Parkinson's disease patientsBelén Fernández, Antonio Jesús Lara Ordóñez, Elena Fdez, et al.
Neurobiology of Aging|January 26, 2010
Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutationEugénie Mutez, Lydie Larvor, Frédéric Leprêtre, et al.
NPJ Parkinson'S Disease|February 7, 2023
Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson's disease and pharmacodynamic biomarkersJean-Marc Taymans, Eugénie Mutez, William Sibran, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 10, 2016
Novel heterozygous mutation in ANO3 responsible for craniocervical dystoniaMorgane Miltgen, Arnaud Blanchard, Hélène Mathieu, et al.
Sensors (Basel, Switzerland)|March 26, 2022
Quantification of Head Tremors in Medical Conditions: A Comparison of Analyses Using a 2D Video Camera and a 3D Wireless Inertial Motion UnitDavid Amarantini, Isabelle Rieu, Giovanni Castelnovo, et al.
The New England Journal of Medicine|November 8, 2023
Trial of Botulinum Toxin for Isolated or Essential Head TremorAna Marques, Bruno Pereira, Marion Simonetta-Moreau, et al.
Journal of Neurology|January 12, 2024
Prognosis of impulse control disorders in Parkinson's disease: a prospective controlled studyThomas Wirth, Thibaut Goetsch, Jean-Christophe Corvol, et al.
Pageof 4